Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.87−0.00 (-0.52%)
Close on Nov 18, 2026Market cap $6.99MP/E –Yield –
Immuron shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2026 it was 297M, up 28.6% from the year before. The highest annual figure on record is 297M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 297M | +28.6% |
| FY2025 | Jun 30, 2025 | 231M | +1.4% |
| FY2024 | Jun 30, 2024 | 228M | +0.0% |
| FY2023 | Jun 30, 2023 | 228M | +0.1% |
| FY2022 | Jun 30, 2022 | 228M | – |
See a number that looks wrong?